StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.18−0.18 (-12.96%)

Close on Nov 16, 2026Market cap $61.66MP/E –Yield –

OKYO Pharma cash

Cash and short-term investments held at the end of each period.

OKYO Pharma's cash was $14.59M at Mar 31, 2026. For fiscal 2026 it was $14.59M, up 835.0% from the year before. The highest annual figure on record is $14.59M in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Mar 31, 2026$14.59M+835.0%
FY2025Mar 31, 2025$1.56M+88.8%
FY2024Mar 31, 2024$826.85K-79.6%
FY2023Mar 31, 2023$4.05M+49.8%
FY2022Mar 31, 2022$2.70M-60.8%
FY2021Mar 31, 2021$6.89M+2825.6%
FY2020Mar 31, 2020$235.49K-62.5%
FY2019Mar 31, 2019$627.62K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ1 2026Mar 31, 2026$14.59M+440.4%
Q4 FY2025CQ1 2025Mar 31, 2025$1.56M-77.3%
Q4 FY2024CQ1 2024Mar 31, 2024$826.85K+251.1%
Q4 FY2023CQ1 2023Mar 31, 2023$4.05M+544.6%
Q4 FY2022CQ1 2022Mar 31, 2022$2.70M–
Q4 FY2021CQ1 2021Mar 31, 2021$6.89M–
Q4 FY2020CQ1 2020Mar 31, 2020$235.49K–
Q4 FY2019CQ1 2019Mar 31, 2019$627.62K–

More OKYO Pharma figures

See a number that looks wrong?